Page last updated: 2024-08-24

3-iodobenzylguanidine and Experimental Hepatoma

3-iodobenzylguanidine has been researched along with Experimental Hepatoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altmann, A; Haberkorn, U; Kissel, M; Kübler, W; Mahmut, M; Peschke, P; Zitzmann, S1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Experimental Hepatoma

ArticleYear
Increased MIBG uptake after transfer of the human norepinephrine transporter gene in rat hepatoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6

    Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Hepatocellular; Cloning, Molecular; Humans; Liver Neoplasms, Experimental; Male; Metabolic Clearance Rate; Neoplasm Transplantation; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Organ Specificity; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Rats; Recombinant Proteins; Reference Values; Symporters; Tissue Distribution; Transduction, Genetic; Tumor Cells, Cultured

2003